Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Income-Including-Non-Controlling-Interests" stands at 178.58 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2023.
Shionogi & Co. Ltd.'s first quarter result of 39.35 Billion JPY for the item "Net Income Including Non Controlling Interests" represents an increase of 8.70 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of 39.35 Billion JPY for the item "Net Income Including Non Controlling Interests" represents an increase of 29.83 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 178.58 Billion JPY for the item "Net Income Including Non Controlling Interests" represents an increase of 5.33 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 20.12 percent compared to the value the year prior.
The 1 year change in percent is 20.12.
The 3 year change in percent is 54.39.
The 5 year change in percent is 48.40.
The 10 year change in percent is 310.54.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Including Non Controlling Interests | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Including Non Controlling Interests | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Including Non Controlling Interests | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Including Non Controlling Interests | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Including Non Controlling Interests | 280,205,508,085.11 |